Sage Journals: Discover world-class research

Retricted access

Research article

First published 2024-02

Establishment of Anti-Dog Programmed Cell Death Ligand 1 Monoclonal Antibodies for Immunohistochemistry

Tsunenori Ouchida, Hiroyuki Suzuki, Tomohiro Tanaka [...]

Monoclonal Antibodies in Immunodiagnosis & Immunotherapy

Open access

Research article

First published 2018

Diverse cutaneous adverse eruptions caused by anti-programmed cell death-1 (PD-1) and anti-programmed cell death ligand-1 (PD-L1) immunotherapies: clinical features and management

John Shen, Jason Chang, Melody Mendenhall [...]

Therapeutic Advances in Medical Oncology

Open access

Research article

First published 2025-11

Screening and verification of anti-programmed death-ligand 1 immunotherapy-sensitive genes in lung squamous cell carcinoma based on bioinformatics

Xinting Zheng, Hao Hu, LeiHao Hu [...]

The International Journal of Biological Markers

Free access

Letter

First published 2016-4

New insights into the anti-PD-L1 and anti-PD-1 reagents in cancer therapy

Cheng Chen, Jian-An Huang

European Journal of Inflammation

Retricted access

Case report

First published 2021-6

Interstitial nephritis with pembrolizumab: A case report and review

A Peláez Bejarano, O Montero Pérez, A Inoriza Rueda [...]

Journal of Oncology Pharmacy Practice

Open access

Review article

First published 2021

The progress and challenge of anti-PD-1/PD-L1 immunotherapy in treating non-small cell lung cancer

Jingjing Qu, Quanhui Mei, Li Liu [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2021

PD-1 Immune Checkpoint Inhibitor Therapy Malignant Tumor Based on Monotherapy and Combined Treatment Research

Yu Zhang, Guang-Ze Mou, Tian-Zhu Li [...]

Technology in Cancer Research & Treatment

Open access

Research article

First published 2020

Rationale and design of a phase II trial of durvalumab treatment in patients with NSCLC ineligible for stage III chemoradiotherapy following radiation monotherapy (SPIRAL-RT study)

Tadaaki Yamada, Junji Uchino, Yusuke Chihara [...]

Therapeutic Advances in Medical Oncology

Open access

Review article

First published 2017-12

Atezolizumab: feasible second-line therapy for patients with non-small cell lung cancer? A review of efficacy,safety and place in therapy

Fanny Jean, Pascale Tomasini, Fabrice Barlesi

Therapeutic Advances in Medical Oncology

Free access

Research article

First published 2022-11

Brain-derived programmed death-ligand 1 mediates immunosuppression post intracerebral hemorrhage

Nuo Cheng, Hong Wang, Ming Zou [...]

Journal of Cerebral Blood Flow & Metabolism

Search results